FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Pernille Ravn

Research Profile

Concepts & Ideas

Disorders

Osteoporosis, Postmenopausal

Chemicals & Drugs

Procedures

Physiology

Co-author Network

Publications

TOP 3
Therese F Nielsen; Pernille Ravn; Joan Pitkin; Claus Christiansen
Pulsed estrogen therapy improves postmenopausal quality of life: a 2-year placebo-controlled study.
Pernille Ravn; Therese F Nielsen; Claus Christiansen
What can be learned from the levormeloxifene experience?
Lise Warming; Pernille Ravn; Claus Christiansen
Levonorgestrel and 17beta-estradiol given transdermally for the prevention of postmenopausal osteoporosis.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Pernille Ravn (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2006: Therese F Nielsen; Pernille Ravn; Joan Pitkin; Claus Christiansen
Pulsed estrogen therapy improves postmenopausal quality of life: a 2-year placebo-controlled study.
Maturitas 2006;53(2):184-90.
2006: Pernille Ravn; Therese F Nielsen; Claus Christiansen
What can be learned from the levormeloxifene experience?
Acta obstetricia et gynecologica Scandinavica 2006;85(2):135-42.
2005: Lise Warming; Pernille Ravn; Claus Christiansen
Levonorgestrel and 17beta-estradiol given transdermally for the prevention of postmenopausal osteoporosis.
Maturitas 2005;50(2):78-85.
2004: Richard D Wasnich; Yu Z Bagger; David J Hosking; Michael R McClung; Mei Wu; Ann Marie Mantz; John J Yates; Philip Ross; Peter Alexandersen; Pernille Ravn; Claus Christiansen; Arthur C Santora
Changes in bone density and turnover after alendronate or estrogen withdrawal.
Menopause (New York, N.Y.) 2004;11(6 Pt 1):622-30.
2004: Pernille Ravn; Lise Warming; Stephan Christgau; Claus Christiansen
The effect on cartilage of different forms of application of postmenopausal estrogen therapy: comparison of oral and transdermal therapy.
Bone 2004;35(5):1216-21.
2004: Michael R McClung; Richard D Wasnich; David J Hosking; Claus Christiansen; Pernille Ravn; Mei Wu; Ann Marie Mantz; John Yates; Philip Ross; Arthur C Santora
Prevention of postmenopausal bone loss: six-year results from the Early Postmenopausal Intervention Cohort Study.
The Journal of clinical endocrinology and metabolism 2004;89(10):4879-85.
2004: Lise Warming; Pernille Ravn; Danièle Spielman; Pierre Delmas; Claus Christiansen
Trimegestone in a low-dose, continuous-combined hormone therapy regimen prevents bone loss in osteopenic postmenopausal women.
Menopause (New York, N.Y.) 2004;11(3):337-42.
2004: Yu Z Bagger; Laszlo Tanko; Peter Alexandersen; Henrik Bo Hansen; Anette Møllgaard; Pernille Ravn; Per Qvist; John A Kanis; Claus Christiansen
Two to three years of hormone replacement treatment in healthy women have long-term preventive effects on bone mass and osteoporotic fractures: the PERF study.
Bone 2004;34(4):728-35.
2004: Lise Warming; Pernille Ravn; T Nielsen; Claus Christiansen
Safety and efficacy of drospirenone used in a continuous combination with 17beta-estradiol for prevention of postmenopausal osteoporosis.
Climacteric : the journal of the International Menopause Society 2004;7(1):103-11.
2004: Therese F Nielsen; Pernille Ravn; Yu Z Bagger; Lise Warming; Claus Christiansen
Pulsed estrogen therapy in prevention of postmenopausal osteoporosis. A 2-year randomized, double blind, placebo-controlled study.
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 2004;15(2):168-74.
2003: Yu Z Bagger; Laszlo Tanko; Peter Alexandersen; Pernille Ravn; Claus Christiansen
Alendronate has a residual effect on bone mass in postmenopausal Danish women up to 7 years after treatment withdrawal.
Bone 2003;33(3):301-7.
2003: Pernille Ravn; Desmond E Thompson; Philip Ross; Claus Christiansen
Biochemical markers for prediction of 4-year response in bone mass during bisphosphonate treatment for prevention of postmenopausal osteoporosis.
Bone 2003;33(1):150-8.
2003: Lise Warming; Pernille Ravn; Claus Christiansen
Visceral fat is more important than peripheral fat for endometrial thickness and bone mass in healthy postmenopausal women.
American journal of obstetrics and gynecology 2003;188(2):349-53.
2002: Lise Warming; Pernille Ravn; S Skouby; Claus Christiansen
Measurement precision and normal range of endometrial thickness in a postmenopausal population by transvaginal ultrasound.
Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology 2002;20(5):492-5.
2002: Pernille Ravn
Bisphosphonates for prevention of postmenopausal osteoporosis.
Danish medical bulletin 2002;49(1):1-18.
2002: Pernille Ravn; G Neugebauer; Claus Christiansen
Association between pharmacokinetics of oral ibandronate and clinical response in bone mass and bone turnover in women with postmenopausal osteoporosis.
Bone 2002;30(1):320-4.
2000: Pernille Ravn; Stuart R Weiss; Jose Adolfo Rodriguez-Portales; Michael R McClung; Richard D Wasnich; N L Gilchrist; P Sambrook; I Fogelman; D Krupa; AJ Yates; Anastasia G Daifotis; G E Fuleihan
Alendronate in early postmenopausal women: effects on bone mass during long-term treatment and after withdrawal. Alendronate Osteoporosis Prevention Study Group.
The Journal of clinical endocrinology and metabolism 2000;85(4):1492-7.
2000: Mya Moe Hla; J W Davis; Philip Ross; J Yates; Richard D Wasnich; Pernille Ravn; Michael R McClung; D Hosking
Relation between body composition and biochemical markers of bone turnover among early postmenopausal women.
Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry 2000;3(4):365-71.
1999: Pernille Ravn; M Bidstrup; Richard D Wasnich; J W Davis; Michael R McClung; A Balske; Carol Coupland; O Sahota; A Kaur; M Daley; Giovanni Cizza
Alendronate and estrogen-progestin in the long-term prevention of bone loss: four-year results from the early postmenopausal intervention cohort study. A randomized, controlled trial.
Annals of internal medicine 1999;131(12):935-42.
1999: Pernille Ravn; Giovanni Cizza; Nina H Bjarnason; D Thompson; M Daley; Richard D Wasnich; Michael R McClung; David J Hosking; AJ Yates; Claus Christiansen
Low body mass index is an important risk factor for low bone mass and increased bone loss in early postmenopausal women. Early Postmenopausal Intervention Cohort (EPIC) study group.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 1999;14(9):1622-7.
1999: Pernille Ravn; David J Hosking; D Thompson; Giovanni Cizza; Richard D Wasnich; Michael R McClung; AJ Yates; Nina H Bjarnason; Claus Christiansen
Monitoring of alendronate treatment and prediction of effect on bone mass by biochemical markers in the early postmenopausal intervention cohort study.
The Journal of clinical endocrinology and metabolism 1999;84(7):2363-8.
1999: Pernille Ravn; B Clemmesen; Claus Christiansen
Biochemical markers can predict the response in bone mass during alendronate treatment in early postmenopausal women. Alendronate Osteoporosis Prevention Study Group.
Bone 1999;24(3):237-44.
1999: Pernille Ravn; Peter Alexandersen; Anette Møllgaard
Bone densitometry: a new, highly responsive region of interest in the distal forearm to monitor the effect of osteoporosis treatment.
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 1999;9(4):277-83.
1998: David J Hosking; Philip Ross; Desmond E Thompson; Richard D Wasnich; Michael R McClung; Nina H Bjarnason; Pernille Ravn; Giovanni Cizza; M Daley; AJ Yates
Evidence that increased calcium intake does not prevent early postmenopausal bone loss.
Clinical therapeutics 1998;20(5):933-44.
1998: SA Earnshaw; N Keating; David J Hosking; Clair E D Chilvers; Pernille Ravn; Michael R McClung; Richard D Wasnich
Tooth counts do not predict bone mineral density in early postmenopausal Caucasian women. EPIC study group.
International journal of epidemiology 1998;27(3):479-83.
1998: Pernille Ravn; J O Christensen; M Baumann; B Clemmesen
Changes in biochemical markers and bone mass after withdrawal of ibandronate treatment: prediction of bone mass changes during treatment.
Bone 1998;22(5):559-64.
1998: David J Hosking; Clair E D Chilvers; Claus Christiansen; Pernille Ravn; Richard D Wasnich; P Ross; Michael R McClung; A Balske; D Thompson; M Daley; AJ Yates
Prevention of bone loss with alendronate in postmenopausal women under 60 years of age. Early Postmenopausal Intervention Cohort Study Group.
The New England journal of medicine 1998;338(8):485-92.
1998: Michael R McClung; B Clemmesen; Anastasia G Daifotis; N L Gilchrist; J Eisman; R S Weinstein; C Reda; AJ Yates; Pernille Ravn
Alendronate prevents postmenopausal bone loss in women without osteoporosis. A double-blind, randomized, controlled trial. Alendronate Osteoporosis Prevention Study Group.
Annals of internal medicine 1998;128(4):253-61.
1997: Pernille Ravn; Mariane Rix; H Andreassen; B Clemmesen; M Bidstrup; M Gunnes
High bone turnover is associated with low bone mass and spinal fracture in postmenopausal women.
Calcified tissue international 1997;60(3):255-60.
1997: B Clemmesen; Pernille Ravn; Brigitte Zegels; AN Taquet; Claus Christiansen; Jean-Yves Reginster
A 2-year phase II study with 1-year of follow-up of risedronate (NE-58095) in postmenopausal osteoporosis.
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 1997;7(5):488-95.
1996: Pernille Ravn; B Clemmesen; B J Riis; Claus Christiansen
The effect on bone mass and bone markers of different doses of ibandronate: a new bisphosphonate for prevention and treatment of postmenopausal osteoporosis: a 1-year, randomized, double-blind, placebo-controlled dose-finding study.
Bone 1996;19(5):527-33.
1996: Philip Ross; Y He; AJ Yates; Carol Coupland; Pernille Ravn; M McClung; D Thompson; Richard D Wasnich
Body size accounts for most differences in bone density between Asian and Caucasian women. The EPIC (Early Postmenopausal Interventional Cohort) Study Group.
Calcified tissue international 1996;59(5):339-43.
1996: Pernille Ravn; C Fledelius; C Rosenquist; K Overgaard; Claus Christiansen
High bone turnover is associated with low bone mass in both pre- and postmenopausal women.
Bone 1996;19(3):291-8.
1996: M M Hla; J W Davis; Philip Ross; Richard D Wasnich; AJ Yates; Pernille Ravn; D J Hosking; M R McClung
A multicenter study of the influence of fat and lean mass on bone mineral content: evidence for differences in their relative influence at major fracture sites. Early Postmenopausal Intervention Cohort (EPIC) Study Group.
The American journal of clinical nutrition 1996;64(3):354-60.
1996: Q Wang; Pernille Ravn; S Wang; K Overgaard; C Hassager; Claus Christiansen
Bone mineral density in immigrants from southern China to Denmark. A cross-sectional study.
European journal of endocrinology / European Federation of Endocrine Societies 1996;134(2):163-7.
1996: Pernille Ravn; K Overgaard; C Huang; Philip Ross; D Green; Michael R McClung
Comparison of bone densitometry of the phalanges, distal forearm and axial skeleton in early postmenopausal women participating in the EPIC Study.
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 1996;6(4):308-13.
1995: Pernille Ravn; C Lind; L Nilas
Lack of influence of simple premenopausal hysterectomy on bone mass and bone metabolism.
American journal of obstetrics and gynecology 1995;172(3):891-5.
1994: Q Wang; C Hassager; Pernille Ravn; S Wang; Claus Christiansen
Total and regional body-composition changes in early postmenopausal women: age-related or menopause-related?
The American journal of clinical nutrition 1994;60(6):843-8.
1994: Pernille Ravn; M L Hetland; K Overgaard; Claus Christiansen
Premenopausal and postmenopausal changes in bone mineral density of the proximal femur measured by dual-energy X-ray absorptiometry.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 1994;9(12):1975-80.